This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Urinary Tract Disorders  • Women's Health, Other  • Alert me on articles by topic

Neil M. Resnick, MD; Derek J. Griffiths, PhD

JAMA. 2003;290:395-397.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

At least 13 million adults in the United States experience urinary incontinence (UI).¹ Most are women, in whom the prevalence of "bothersome incontinence" increases from 2% between the ages of 20 and 24 years to 9% at 50-54 years and to 16% at 85 years.² The annual direct costs of UI in the United States are estimated at $12.4 billion for women and $3.8 billion for men (in 1995 US dollars),³ similar to estimates for osteoporosis, arthritis, Alzheimer disease, human immunodeficiency virus, and AIDS.¹ However, these estimates are conservative because the majority of individuals with UI are unknown to their physician and thus are neither evaluated nor treated. In addition, neither the substantial indirect costs nor the attendant medical or psychosocial morbidity are included in estimates of its impact. Despite these considerations, UI remains relatively neglected by clinicians and researchers alike¹ even . . . [Full Text of this Article]

RELATED ARTICLE

Effect of Behavioral Training With or Without Pelvic Floor Electrical Stimulation on Stress Incontinence in Women: A Randomized Controlled Trial
Patricia S. Goode, Kathryn L. Burgio, Julie L. Locher, David L. Roth, Mary G. Umlauf, Holly E. Richter, R. Edward Varner, and L. Keith Lloyd
JAMA. 2003;290(3):345-352.
ABSTRACT | FULL TEXT